Matthew Dellatorre
Stock Analyst at Goldman Sachs
(4.44)
# 1,102
Out of 4,429 analysts
19
Total ratings
92.9%
Success rate
49.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Dellatorre
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMRX Amneal Pharmaceuticals | Reiterated: Buy | $17 | $16.11 | +5.56% | 6 | May 27, 2026 | |
| TEVA Teva Pharmaceutical Industries | Maintained: Buy | $45 | $32.20 | +39.75% | 9 | Apr 1, 2026 | |
| VTRS Viatris | Reiterated: Hold | $10 → $12 | $15.38 | -21.98% | 4 | Oct 22, 2025 |
Amneal Pharmaceuticals
May 27, 2026
Reiterated: Buy
Price Target: $17
Current: $16.11
Upside: +5.56%
Teva Pharmaceutical Industries
Apr 1, 2026
Maintained: Buy
Price Target: $45
Current: $32.20
Upside: +39.75%
Viatris
Oct 22, 2025
Reiterated: Hold
Price Target: $10 → $12
Current: $15.38
Upside: -21.98%